On January 7, 2019 Innate Pharma SA (the "Company" – Euronext Paris: FR0010331421 – IPH) reported that it will be present at the following investor events in the first quarter 2019 (Press release, Innate Pharma, JAN 7, 2019, View Source [SID1234532549]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

– LifeSci Advisors 1×1 Meetings surrounding the J.P. Morgan Annual Healthcare Conference– San Francisco, January 7-10, 2019

– Oddo BHF Forum – Lyon, January 10-11, 2019

– Degroof Petercam’s Healthcare Seminar – Brussels, January 31, 2019

– Leerink Partners Annual Global Healthcare Conference – NYC, February 27 – March 1, 2019

– Credit Suisse Global Healthcare Conference – London, March 5-6, 2019

– Oppenheimer Annual Healthcare Conference – NYC, March 19-20, 2019

Innate Pharma is committed to meet on a regular basis with the financial community. All corporate information on the Company, such as its financial statements or its corporate presentations, is available on the Company’s websitein the Investors’ section (www.innate-pharma.com/en/investors).